Page last updated: 2024-10-16

acetone and Glycogen Storage Disease Type I

acetone has been researched along with Glycogen Storage Disease Type I in 1 studies

methyl ketone : A ketone of formula RC(=O)CH3 (R =/= H).

Glycogen Storage Disease Type I: An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fernandes, J1
Pikaar, NA1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type I[NCT03665636]Early Phase 14 participants (Actual)Interventional2020-10-16Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for acetone and Glycogen Storage Disease Type I

ArticleYear
Ketosis in hepatic glycogenosis.
    Archives of disease in childhood, 1972, Volume: 47, Issue:251

    Topics: Acetone; Acidosis; Adolescent; Adult; Age Factors; Blood Glucose; Caseins; Child; Child, Preschool;

1972